Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailSuivi sanitaire des cervidés sauvages en Région Wallonne
Linden, Annick ULg

Article for general public (2002)

Detailed reference viewed: 13 (3 ULg)
Full Text
See detailSuivi satellitaire de la migration automnale de la cigogne noire. Aléas et perspectives d'avenir
Libois, Roland ULg; Jadoul, Gérard

in Aves (1997), 34(1), 20-22

Detailed reference viewed: 11 (1 ULg)
See detailLe sujet de l'histoire
Denis, Benoît ULg

in Durand, Pascal (Ed.) L'écrivain et son double. Hubert Nyssen (2006)

Detailed reference viewed: 6 (0 ULg)
See detailSujet et objet dans le processus de recherche: le cas de l'entretien semi-directif
Naziri, Despina ULg

in Psychologika Themata (1990), 3(3), 175-182

Detailed reference viewed: 11 (1 ULg)
See detailUn sujet obese par une approche multidisciplinaire: l'exemple du Centre de l'Obesite du CHU Ourthe-Ambleve.
Scheen, André ULg; Rorive, Marcelle ULg; Letiexhe, Michel ULg et al

in Revue Médicale de Liège (2001), 56(7), 474-9

Obesity is a mulfactorial disease whose prevalence is progressively increasing. Ideally, it requires a multidisciplinary management by medical doctors, dieticians, psychologists and kinetherapists. The ... [more ▼]

Obesity is a mulfactorial disease whose prevalence is progressively increasing. Ideally, it requires a multidisciplinary management by medical doctors, dieticians, psychologists and kinetherapists. The new "Centre de l'Obesite" at the University of Liege aims at fulfilling such objectives with: 1) a first outpatient visit including the simultaneous participation of an endocrinologist, a dietician and a psychologist; 2) a structured and individualized programme of physical rehabilitation; 3) an individualized management of obese subjects as in-(hospital) and/or outpatients, using medical and/or surgical approaches; and 4) an opportunity to benefit of other specialized medical advices, if necessary, in order to increase both the efficacy and safety of the treatment. Owing to the increasing importance of obesity and the well-known difficulties to succeed in treating it, general practitioners should consider this new centre as a valuable help rather than a competitive structure for the management of their patients, especially those with severe or morbid obesity. [less ▲]

Detailed reference viewed: 72 (4 ULg)
Full Text
See detailSujets de poids normal «métaboliquement obèses» et sujets obèses «métaboliquement sains»
Beck, Emmanuel ULg; Esser, Nathalie; Paquot, Nicolas ULg et al

in Revue Médicale de la Suisse Romande (2009), 5

Les relations entre poids corporel et anomalies métaboliques ne sont pas univoques. Ainsi, il existe des personnes non obèses métaboliquement anormales (MONW), rarement dépistées en raison d’un poids ... [more ▼]

Les relations entre poids corporel et anomalies métaboliques ne sont pas univoques. Ainsi, il existe des personnes non obèses métaboliquement anormales (MONW), rarement dépistées en raison d’un poids corporel faussement rassurant, et, à l’inverse, des sujets métaboliquement sains bien qu’ils soient obè ses (MHO). La topographie (intra-abdominale/hépatique vs sous-cutanée périphérique) et l’activité hormono-métabolique et pro-inflammatoire différente des dépôts graisseux semblent jouer un rôle déterminant pour expliquer ce paradoxe. Cet article de revue vise à décrire les grands principes de la prise en charge thérapeutique des personnes MONW, dans le but de réduire le risque accru de diabète de type 2 et de maladies cardiovasculaires, et de discuter les avantages et inconvénients d’une prise en charge classique de l’obésité chez les patients MHO. [less ▲]

Detailed reference viewed: 52 (2 ULg)
Full Text
See detailSujets obèses sans anomalies métaboliques
Esser, Nathalie; Scheen, André ULg

in Revue Médicale de Liège (2009), 64(3), 148-157

Obesity, especially abdominal obesity, is the main risk factor of metabolic syndrome. However, there are obviously non obese individuals who are metabolically abnormal and therefore exposed to an ... [more ▼]

Obesity, especially abdominal obesity, is the main risk factor of metabolic syndrome. However, there are obviously non obese individuals who are metabolically abnormal and therefore exposed to an increased risk of cardiovascular complications. Unfortunately, those persons fail to be detected because of a falsely reassuring body weight. The present paper aims at better understanding the etiopathogenesis and pathophysiology of this particular phenotype, at evaluating its potential clinical consequences and at describing the main principles of its therapeutic management. [less ▲]

Detailed reference viewed: 32 (6 ULg)
Full Text
See detailSujets « métaboliquement obèses » de poids normal. Première partie: diagnostic, physiopathologie et prévalence
Beck, Emmanuel ULg; Paquot, Nicolas ULg; Scheen, André ULg

in Obésité (2008), 3(3), 184-193

Obesity, particularly abdominal obesity, is the main risk factor for metabolic syndrome. However, some non-obese individuals are metabolically abnormal and therefore probably have an increased risk of ... [more ▼]

Obesity, particularly abdominal obesity, is the main risk factor for metabolic syndrome. However, some non-obese individuals are metabolically abnormal and therefore probably have an increased risk of cardiovascular disease. The present review paper aims to describe the main characteristics of the metabolically obese normal-weight (MONW) syndrome, analyse its etiopathogenesis and pathophysiology and, finally, assess its prevalence in various populations. [less ▲]

Detailed reference viewed: 58 (2 ULg)
Full Text
See detailSujets « métaboliquement obèses » de poids normal. Seconde partie: pronostic et prise en charge
Beck, Emmanuel ULg; Paquot, Nicolas ULg; Scheen, André ULg

in Obésité (2008), 3(4), 280-285

Metabolically obese normal-weight (MONW) individuals are frequently not detected because of a falsely reassuring body weight. However, they have most of the metabolic syndrome markers known to be ... [more ▼]

Metabolically obese normal-weight (MONW) individuals are frequently not detected because of a falsely reassuring body weight. However, they have most of the metabolic syndrome markers known to be associated with a higher risk of type 2 diabetes, cardiovascular disease and mortality. The present review paper aims to describe the clinical consequences to which MONW people are exposed and the main principles of managing this syndrome [less ▲]

Detailed reference viewed: 29 (3 ULg)